Mutual of America Capital Management LLC Has $5.52 Million Holdings in Humana Inc. (NYSE:HUM)

Mutual of America Capital Management LLC boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 0.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 21,759 shares of the insurance provider’s stock after acquiring an additional 42 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Humana were worth $5,520,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Creative Financial Designs Inc. ADV boosted its position in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the period. Ashton Thomas Securities LLC acquired a new stake in shares of Humana during the 3rd quarter valued at about $31,000. FPC Investment Advisory Inc. acquired a new stake in shares of Humana during the 4th quarter valued at about $27,000. Centricity Wealth Management LLC acquired a new stake in shares of Humana during the 4th quarter valued at about $30,000. Finally, Atwood & Palmer Inc. lifted its holdings in shares of Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after buying an additional 60 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.32% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Wells Fargo & Company reduced their price target on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Barclays lifted their price target on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Morgan Stanley reduced their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, February 12th. Royal Bank of Canada reiterated an “outperform” rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Finally, TD Cowen raised their price objective on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Nineteen analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $285.68.

Humana Stock Performance

Shares of NYSE HUM opened at $261.65 on Tuesday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The business’s 50 day moving average is $271.23 and its two-hundred day moving average is $285.69. The company has a market cap of $31.57 billion, a P/E ratio of 26.30, a P/E/G ratio of 2.05 and a beta of 0.56. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46.

Humana (NYSE:HUM) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.35%. The ex-dividend date is Friday, March 28th. Humana’s payout ratio is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.